Follow our progress.

Milestones in our journey to reinvent genetic testing.

View full list

Press Releases

Invitae to announce fourth quarter and year-end 2015 financial results and host conference call on February 9, 2016

Invitae to announce fourth quarter and year-end 2015 financial results and host conference call on February 9, 2016

January 26, 2016

Management to present at Leerink Partners 5th Annual Global Healthcare Conference on February 11, 2016 

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it will report its fourth quarter and year-end 2015 financial results on Tuesday, February 9, 2016, and Invitae’s management team will host a conference call that day at 4:45 p.m. Eastern / 1:45 p.m. Pacific to discuss the financial results and recent developments.

The dial-in numbers for the conference call are (866) 393-4306 for domestic callers and (734) 385-2616 for international callers, and the reservation number for both is 24115796.

Invitae also announced that it will present at the Leerink Partners 5th Annual Global Healthcare Conference on Thursday, February 11, 2016 at 10:45 a.m. Eastern / 7:45 a.m. Pacific. 

The live, listen-only webcasts of both the conference call and presentation at Leerink may be accessed by visiting the investors section of the company's website at ir.invitae.com. A replay of the webcasts will be available shortly after the conclusions of the call and presentation and will be archived on the company's website.

About Invitae

Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae’s goal is to aggregate most of the world’s genetic tests into a single service with higher quality, faster turnaround time, and lower price than many single-gene and panel tests today. The company currently provides a single diagnostic service comprising hundreds of genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics and other rare disease areas.

For more information, visit our website at ir.invitae.com and follow us on Twitter: @invitae and @invitaeIR.

Source: Invitae Corporation

Contact:
Laura D’Angelo
pr@invitae.com
314-920-0617

Share

Return to press releases